Literature DB >> 7808691

Diabetic cardiomyopathy: experimental and clinical observations.

T J Regan1, S Ahmed, B Haider, C Moschos, A Weisse.   

Abstract

Heart failure, arrhythmia, or chest pain can be a consequence of diabetes independent of coronary disease or hypertension. Diastolic myocardial dysfunction is common, contributing to the high mortality during acute infarction. The authors discuss diabetic cardiomyopathy and its management.

Entities:  

Mesh：

Year:  1994        PMID： 7808691

Source DB:  PubMed          Journal:  N J Med        ISSN： 0885-842X


  10 in total

1.  Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Sándor Bátkai; Malek Kechrid; Partha Mukhopadhyay; Wen-Shin Lee; Béla Horváth; Eileen Holovac; Resat Cinar; Lucas Liaudet; Ken Mackie; György Haskó; Pál Pacher
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

2.  MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes.

Authors:  Fang Zhao; Bo Li; Yin-Zhi Wei; Bin Zhou; Han Wang; Ming Chen; Xue-Dong Gan; Zhao-Hui Wang; Shi-Xi Xiong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

Review 3.  Mechanisms of subcellular remodeling in heart failure due to diabetes.

Authors:  Naranjan S Dhalla; Nobuakira Takeda; Delfin Rodriguez-Leyva; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 4.  Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

Authors:  Pál Pacher; Irina G Obrosova; Jon G Mabley; Csaba Szabó
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

5.  Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; Vivek Patel; Keita Saito; Shingo Matsumoto; Yoshihiro Kashiwaya; Béla Horváth; Bani Mukhopadhyay; Lauren Becker; György Haskó; Lucas Liaudet; David A Wink; Aristidis Veves; Raphael Mechoulam; Pál Pacher
Journal:  J Am Coll Cardiol       Date:  2010-12-14       Impact factor: 24.094

6.  Left bundle branch block in type 2 diabetes mellitus: a sign of advanced cardiovascular involvement.

Authors:  Eliscer Guzman; Narpinder Singh; Ijaz A Khan; Andreas P Niarchos; Cherian Verghese; Cesare Saponieri; Harinder K Singh; Ramesh M Gowda; Balendu C Vasavada; Ronny A Cohen
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

7.  Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart.

Authors:  Zainisha Vasanji; Naranjan S Dhalla; Thomas Netticadan
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

8.  Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI).

Authors:  Xichun Yu; Yasvir A Tesiram; Rheal A Towner; Andrew Abbott; Eugene Patterson; Shijun Huang; Marion W Garrett; Suresh Chandrasekaran; Satoshi Matsuzaki; Luke I Szweda; Brian E Gordon; David C Kem
Journal:  Cardiovasc Diabetol       Date:  2007-02-19       Impact factor: 9.951

9.  Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; Bani Mukhopadhyay; Vivek Patel; György Haskó; Csaba Szabó; Jon G Mabley; Lucas Liaudet; Pál Pacher
Journal:  J Cell Mol Med       Date:  2008-10-23       Impact factor: 5.295

Review 10.  Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.

Authors:  Naranjan S Dhalla; Anureet K Shah; Paramjit S Tappia
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.